Thomas Rives, MD
General Practice · Little River, SCNPI 1457342370
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$835
- Novo Nordisk$539
- Amgen$296
- AbbVie$216
- Lilly USA, LLC$153
- GSK$147
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,034100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $835 |
| Novo Nordisk | 29 | $539 |
| Amgen(2 entities) | 17 | $296 |
| AbbVie | 12 | $216 |
| Lilly USA, LLC | 11 | $153 |
| GSK | 9 | $147 |
| Amarin Pharma, Inc. | 8 | $140 |
| Exact Sciences | 9 | $138 |
| Atricure, Inc. | 1 | $136 |
| Johnson & Johnson | 7 | $118 |
| Abbott | 5 | $103 |
| Daiichi Sankyo Inc. | 4 | $84 |
| Mylan Specialty L.p. | 4 | $82 |
| Bayer | 4 | $68 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| Novartis | 4 | $68 |
| Boehringer Ingelheim | 4 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Hologic Sales And Service, LLC | 3 | $60 |
| Astellas Pharma US Inc | 3 | $57 |
| Pfizer | 4 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Merck | 4 | $51 |
| Boston Scientific | 2 | $50 |
| Eisai Inc. | 3 | $45 |
| Idorsia Pharmaceuticals US Inc | 3 | $39 |
| Viatris Specialty LLC | 2 | $38 |
| Nevro Corp. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Dexcom, Inc. | 1 | $30 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Intra-sana Laboratories | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 2 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,047 in reported general payments places this provider in the 95th percentile of 1,367 general practice providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 159 | $185,664 |
| FarxigaDapagliflozin Propanediol | 145 | $149,249 |
| EliquisApixaban | 109 | $117,146 |
| OzempicSemaglutide | 51 | $84,340 |
| JardianceEmpagliflozin | 72 | $79,895 |
| TrulicityDulaglutide | 53 | $76,200 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $59,724 |
| JanuviaSitagliptin Phosphate | 50 | $41,136 |
| XareltoRivaroxaban | 20 | $29,226 |
| TradjentaLinagliptin | 22 | $28,633 |
| Repatha SureclickEvolocumab | 23 | $23,526 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 23 | $21,580 |
| LinzessLinaclotide | 18 | $14,509 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $12,344 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $12,254 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $153 | $261,864212 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $835 | $161,503160 claims |
| PfizerEliquis | $55 | $117,146109 claims |
| Boehringer IngelheimJardiance, Tradjenta | $68 | $108,52894 claims |
| Novo NordiskOzempic | $539 | $84,34051 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $147 | $66,57077 claims |
| MerckJanuvia | $51 | $41,13650 claims |
| Johnson & JohnsonXarelto | $118 | $29,22620 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $32 | $21,58023 claims |
| AbbVieLinzess, Synthroid | $216 | $18,65465 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,367 general practice providers in South Carolina.
Other general practice in Little River
- Joseph GrantSumter$187K
- Christopher CampbellLexington$166K
- Jeffrey HorowitzMurrells Inlet$152K
- Amanda SeayMount Pleasant$146K
- Jon JulianTravelers Rest$141K
- Timothy SniderGreenwood$122K
- Anthony MennitoBamberg$120K
- Coty FishburneRock Hill$119K
- Rukudzo MazaiwanaOrangeburg$70K
- Benjamin DanielGreenville$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.